ICH guideline
ICH S9: Nonclinical Evaluation for Anticancer Pharmaceuticals
ICH guideline · Safety Guidelines · Step 5
Key facts
| ICH code | S9 |
|---|---|
| Title | Nonclinical Evaluation for Anticancer Pharmaceuticals |
| Guideline series | Safety Guidelines |
| ICH step | Step 5 |
| ICH summary (excerpt) | The ICH Harmonised Guideline was adopted under Step 4 in October 2009. This Guideline provides information for pharmaceuticals that are intended to treat cancer in patients with late stage or advanced disease regardless of the route of administration, including both small molecule and biotechnology-derived… |
| File | S9 Step 4 Presentation |
| File type | |
| File on ich.org | database.ich.org |
At a glance
- No Full text searchable in Orca1
- S9 Step 4 Presentation Files published by ICH
- 1–9 FDA guidance documents based on this guideline
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ICH guidelines
ICH guidelines harmonise the technical requirements for registering medicines in the ICH regions. Each guideline moves through a five-step process, from concept paper to adoption and implementation by regulators.